Cargando…

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation

Accurate measurement of the marginal healthcare costs associated with different diseases and health conditions is important, especially for increasingly prevalent conditions such as obesity. However, existing observational study designs cannot identify the causal impact of disease on healthcare cost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, Padraig, Davey Smith, George, von Hinke, Stephanie, Davies, Neil M., Hollingworth, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073110/ https://www.ncbi.nlm.nih.gov/pubmed/27484822 http://dx.doi.org/10.1007/s40273-016-0432-x

Ejemplares similares

Mendelian Randomization analysis of the causal effect of adiposity on hospital costs
por: Dixon, Padraig, et al.
Publicado: (2020)

The many weak instruments problem and Mendelian randomization
por: Davies, Neil M, et al.
Publicado: (2015)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM
por: Pokhilenko, Irina, et al.
Publicado: (2023)

Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators
por: Pierce, Brandon L., et al.
Publicado: (2013)

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom
por: Whitehurst, David G. T., et al.
Publicado: (2018)

Stakeholder Engagement in the Development of Public Health Economic Models: An Application to Modelling of Minimum Unit Pricing of Alcohol in South Africa
por: Gibbs, N. K., et al.
Publicado: (2023)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency
por: Shields, Gemma E., et al.
Publicado: (2021)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

The Association Between Adiposity and Inpatient Hospital Costs in the UK Biobank Cohort
por: Dixon, Padraig, et al.
Publicado: (2018)

Involving Patients in Health Economics Research: “The PACTS Principles”
por: Hawton, Annie, et al.
Publicado: (2020)

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
por: Sendi, Pedram
Publicado: (2020)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19
por: Soofi, Moslem, et al.
Publicado: (2020)

Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice
por: Gomes, Manuel, et al.
Publicado: (2022)

Conducting Trial-Based Economic Evaluations Using R: A Tutorial
por: Ben, Ângela Jornada, et al.
Publicado: (2023)

Genetic markers as instrumental variables
por: von Hinke, Stephanie, et al.
Publicado: (2016)

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
por: Kandiyali, Rebecca, et al.
Publicado: (2018)

Patient and Public Involvement (PPI) in Health Economics Methodology Research: Reflections and Recommendations
por: Al-Janabi, Hareth, et al.
Publicado: (2020)

Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study
por: Harrison, Sean, et al.
Publicado: (2021)

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines
por: Painter, Chris, et al.
Publicado: (2021)

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
por: Kent, Seamus, et al.
Publicado: (2019)

Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study
por: Jacobsen, Elisabet, et al.
Publicado: (2020)

Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States
por: Xie, Richard Z., et al.
Publicado: (2021)

On the Use of the Lasso for Instrumental Variables Estimation with Some Invalid Instruments
por: Windmeijer, Frank, et al.
Publicado: (2018)

Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage
por: Maniadakis, Nikolaos, et al.
Publicado: (2018)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses
por: Naylor, Nichola R., et al.
Publicado: (2022)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kf6pt5dgb72mtjm16hjjtqfthr